Cargando…
Herpesvirus Vectors for Therapy of Brain Tumors
Genetically modified, conditionally-replicating Herpes Simplex Virus Type 1 (HSV-1) vectors for the treatment of malignant glioma have provided encouraging results in the handful of Phase I and Phase II clinical trials conducted to date. In recent years, a number of new strategies have been develope...
| Autores principales: | , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Bentham Open
2010
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2930154/ https://www.ncbi.nlm.nih.gov/pubmed/20811578 http://dx.doi.org/10.2174/1874357901004010103 |